Literature DB >> 27238970

An Engineered Switch in T Cell Receptor Specificity Leads to an Unusual but Functional Binding Geometry.

Daniel T Harris1, Nishant K Singh2, Qi Cai1, Sheena N Smith1, Craig Vander Kooi3, Erik Procko1, David M Kranz1, Brian M Baker2.   

Abstract

Utilizing a diverse binding site, T cell receptors (TCRs) specifically recognize a composite ligand comprised of a foreign peptide and a major histocompatibility complex protein (MHC). To help understand the determinants of TCR specificity, we studied a parental and engineered receptor whose peptide specificity had been switched via molecular evolution. Altered specificity was associated with a significant change in TCR-binding geometry, but this did not impact the ability of the TCR to signal in an antigen-specific manner. The determinants of binding and specificity were distributed among contact and non-contact residues in germline and hypervariable loops, and included disruption of key TCR-MHC interactions that bias αβ TCRs toward particular binding modes. Sequence-fitness landscapes identified additional mutations that further enhanced specificity. Our results demonstrate that TCR specificity arises from the distributed action of numerous sites throughout the interface, with significant implications for engineering therapeutic TCRs with novel and functional recognition properties.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27238970      PMCID: PMC4938795          DOI: 10.1016/j.str.2016.04.011

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  29 in total

1.  Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical.

Authors:  Y H Ding; B M Baker; D N Garboczi; W E Biddison; D C Wiley
Journal:  Immunity       Date:  1999-07       Impact factor: 31.745

2.  How structural adaptability exists alongside HLA-A2 bias in the human αβ TCR repertoire.

Authors:  Sydney J Blevins; Brian G Pierce; Nishant K Singh; Timothy P Riley; Yuan Wang; Timothy T Spear; Michael I Nishimura; Zhiping Weng; Brian M Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-16       Impact factor: 11.205

3.  Generation of peptide-MHC class I complexes through UV-mediated ligand exchange.

Authors:  Boris Rodenko; Mireille Toebes; Sine Reker Hadrup; Wim J E van Esch; Annemieke M Molenaar; Ton N M Schumacher; Huib Ovaa
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

4.  A flexible docking approach for prediction of T cell receptor-peptide-MHC complexes.

Authors:  Brian G Pierce; Zhiping Weng
Journal:  Protein Sci       Date:  2013-01       Impact factor: 6.725

5.  T cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex.

Authors:  Dennis X Beringer; Fleur S Kleijwegt; Florian Wiede; Arno R van der Slik; Khai Lee Loh; Jan Petersen; Nadine L Dudek; Gaby Duinkerken; Sandra Laban; Antoinette Joosten; Julian P Vivian; Zhenjun Chen; Adam P Uldrich; Dale I Godfrey; James McCluskey; David A Price; Kristen J Radford; Anthony W Purcell; Tatjana Nikolic; Hugh H Reid; Tony Tiganis; Bart O Roep; Jamie Rossjohn
Journal:  Nat Immunol       Date:  2015-10-05       Impact factor: 25.606

Review 6.  Structural and dynamic control of T-cell receptor specificity, cross-reactivity, and binding mechanism.

Authors:  Brian M Baker; Daniel R Scott; Sydney J Blevins; William F Hawse
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

7.  T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex.

Authors:  Jarrett J Adams; Samanthi Narayanan; Baoyu Liu; Michael E Birnbaum; Andrew C Kruse; Natalie A Bowerman; Wei Chen; Aron M Levin; Janet M Connolly; Cheng Zhu; David M Kranz; K Christopher Garcia
Journal:  Immunity       Date:  2011-11-23       Impact factor: 31.745

8.  Increased Peptide Contacts Govern High Affinity Binding of a Modified TCR Whilst Maintaining a Native pMHC Docking Mode.

Authors:  David K Cole; Malkit Sami; Daniel R Scott; Pierre J Rizkallah; Oleg Y Borbulevych; Penio T Todorov; Ruth K Moysey; Bent K Jakobsen; Jonathan M Boulter; Brian M Baker
Journal:  Front Immunol       Date:  2013-06-26       Impact factor: 7.561

9.  Computational design of the affinity and specificity of a therapeutic T cell receptor.

Authors:  Brian G Pierce; Lance M Hellman; Moushumi Hossain; Nishant K Singh; Craig W Vander Kooi; Zhiping Weng; Brian M Baker
Journal:  PLoS Comput Biol       Date:  2014-02-13       Impact factor: 4.475

10.  Structural interplay between germline interactions and adaptive recognition determines the bandwidth of TCR-peptide-MHC cross-reactivity.

Authors:  Jarrett J Adams; Samanthi Narayanan; Michael E Birnbaum; Sachdev S Sidhu; Sydney J Blevins; Marvin H Gee; Leah V Sibener; Brian M Baker; David M Kranz; K Christopher Garcia
Journal:  Nat Immunol       Date:  2015-11-02       Impact factor: 25.606

View more
  15 in total

1.  Improving T Cell Receptor On-Target Specificity via Structure-Guided Design.

Authors:  Lance M Hellman; Kendra C Foley; Nishant K Singh; Jesus A Alonso; Timothy P Riley; Jason R Devlin; Cory M Ayres; Grant L J Keller; Yuting Zhang; Craig W Vander Kooi; Michael I Nishimura; Brian M Baker
Journal:  Mol Ther       Date:  2018-12-14       Impact factor: 11.454

2.  A generalized framework for computational design and mutational scanning of T-cell receptor binding interfaces.

Authors:  Timothy P Riley; Cory M Ayres; Lance M Hellman; Nishant K Singh; Michael Cosiano; Jennifer M Cimons; Michael J Anderson; Kurt H Piepenbrink; Brian G Pierce; Zhiping Weng; Brian M Baker
Journal:  Protein Eng Des Sel       Date:  2016-09-13       Impact factor: 1.650

3.  Deep Mutational Scans as a Guide to Engineering High Affinity T Cell Receptor Interactions with Peptide-bound Major Histocompatibility Complex.

Authors:  Daniel T Harris; Ningyan Wang; Timothy P Riley; Scott D Anderson; Nishant K Singh; Erik Procko; Brian M Baker; David M Kranz
Journal:  J Biol Chem       Date:  2016-09-28       Impact factor: 5.157

4.  An Engineered T Cell Receptor Variant Realizes the Limits of Functional Binding Modes.

Authors:  Nishant K Singh; Jesus A Alonso; Daniel T Harris; Scott D Anderson; Jiaqi Ma; Lance M Hellman; Aaron M Rosenberg; Elizabeth M Kolawole; Brian D Evavold; David M Kranz; Brian M Baker
Journal:  Biochemistry       Date:  2020-10-19       Impact factor: 3.162

5.  Subtle changes at the variable domain interface of the T-cell receptor can strongly increase affinity.

Authors:  Preeti Sharma; David M Kranz
Journal:  J Biol Chem       Date:  2017-12-11       Impact factor: 5.157

Review 6.  Emerging Concepts in TCR Specificity: Rationalizing and (Maybe) Predicting Outcomes.

Authors:  Nishant K Singh; Timothy P Riley; Sarah Catherine B Baker; Tyler Borrman; Zhiping Weng; Brian M Baker
Journal:  J Immunol       Date:  2017-10-01       Impact factor: 5.422

7.  Mapping Interaction Sites on Human Chemokine Receptors by Deep Mutational Scanning.

Authors:  Jeremiah D Heredia; Jihye Park; Riley J Brubaker; Steven K Szymanski; Kevin S Gill; Erik Procko
Journal:  J Immunol       Date:  2018-04-20       Impact factor: 5.422

8.  T-cell Receptors Engineered De Novo for Peptide Specificity Can Mediate Optimal T-cell Activity without Self Cross-Reactivity.

Authors:  Preeti Sharma; Daniel T Harris; Jennifer D Stone; David M Kranz
Journal:  Cancer Immunol Res       Date:  2019-09-23       Impact factor: 11.151

9.  Structure-guided engineering of the affinity and specificity of CARs against Tn-glycopeptides.

Authors:  Preeti Sharma; Venkata V V R Marada; Qi Cai; Monika Kizerwetter; Yanran He; Steven P Wolf; Karin Schreiber; Henrik Clausen; Hans Schreiber; David M Kranz
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-15       Impact factor: 11.205

Review 10.  The intersection of affinity and specificity in the development and optimization of T cell receptor based therapeutics.

Authors:  Timothy P Riley; Brian M Baker
Journal:  Semin Cell Dev Biol       Date:  2018-12       Impact factor: 7.499

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.